Crosstalk between kidney and bones: New perspective for modulating osteoporosis
- 17 May 2025
- journal article
- review article
- Published by Elsevier in Ageing Research Reviews
- Vol. 109, 102776
Abstract
No abstract availableKeywords
Funding Information
- Education Department of Hunan Province (CX20230802)
- Hunan Provincial Natural Science Foundation (2023JJ60473)
- China Hunan Provincial Science and Technology Department (2023SK2048, 2021CB1012)
- Hunan University of Chinese Medicine (202302)
This publication has 201 references indexed in Scilit:
- Prevalence of Osteoporosis and Fracture in ChinaJAMA Network Open, 2021
- Opportunistic Screening Using Low-Dose CT and the Prevalence of Osteoporosis in China: A Nationwide, Multicenter StudyJournal of Bone and Mineral Research, 2020
- Klotho Lacks an FGF23-Independent Role in Mineral HomeostasisJournal of Bone and Mineral Research, 2017
- Identification of Hip BMD Loss and Fracture Risk Markers Through Population-Based Serum ProteomicsJournal of Bone and Mineral Research, 2017
- Increased EPO Levels Are Associated With Bone Loss in Mice Lacking PHD2 in EPO-Producing CellsJournal of Bone and Mineral Research, 2016
- Overexpression of vasostatin‐1 protects hypoxia/reoxygenation injuries in cardiomyocytes–endothelial cells transwell co‐culture systemCell Biology International, 2013
- Renal safety in patients treated with bisphosphonates for osteoporosis: A reviewJournal of Bone and Mineral Research, 2013
- SNP rs6265 Regulates Protein Phosphorylation and Osteoblast Differentiation and Influences BMD in HumansJournal of Bone and Mineral Research, 2013
- Osteoblast extracellular Ca2+-sensing receptor regulates bone development, mineralization, and turnoverJournal of Bone and Mineral Research, 2011
- Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease OutcomesThe NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 TrialJAMA, 2006